Delivery Order SPE2DX22D0020-SPE2D826F13BD
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,116.36 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's parent company Cencora, Inc., which operates under the trade name AmerisourceBergen. The contract was competitively awarded with no set-aside designation and will be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $1.17M firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0), the Corporate Office division of parent company Cencora, Inc. This non-set-aside, competitively awarded delivery order, issued on January 8, 2026, will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of January 9, 2026. The delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,379.98 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on January 5, 2026, with an ultimate completion date of January 6, 2026. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle established through December 2026. The order is to be performed at the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $190,474.69 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on January 6, 2026, with completion expected by January 7, 2026. This non-competitive, non-set-aside order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9 million through December 2031. The contract vehicle...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $20,283.10 to AmerisourceBergen Drug Corp (Cage 0U9U0) on January 6, 2026, with an ultimate completion date of January 7, 2026. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support...
- Amerisourcebergen Drug Corp (CAGE 0U9U0), a subsidiary of Cencora, Inc., was awarded a delivery order valued at $61,175.40 on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price contract was issued with no set-aside designation through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate office. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $151,353.72 to AmerisourceBergen Drug Corp (CAGE: 0U9U0) on January 5, 2026, with an ultimate completion date of January 6, 2026. This non-set-aside delivery order is being performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,900.86 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 12, 2025, with an ultimate completion date of December 15, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider to federal medical procurement programs,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 29, 2025, valued at $34,961.88 under a firm fixed-price, non-set-aside contract. This delivery order, which is a child action under a larger contract vehicle, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $2,412.16 to AmerisourceBergen Drug Corp (CAGE: 0U9U0) on June 30, 2025, with an ultimate completion date of July 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The place of performance is...
- SPE2DX22D0020Indefinite Delivery Contract
- SPE2DX22D0020-SPE2D826F13BDDelivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,375.10 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a subsidiary of parent company Cencora, Inc., on January 9, 2026, with an ultimate completion date of January 12, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger vehicle supporting federal medical procurement operations. AmerisourceBergen Drug Corp operates as a critical pharmaceutical distributor and healthcare solutions provider within the Defense Logistics Agency's medical supply chain network, supplying an extensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems globally. The company holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which serves as the overarching contract vehicle enabling delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support defense health operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 1/8/26 |